ES2206770T3 - Particulas secas fluidas. - Google Patents

Particulas secas fluidas.

Info

Publication number
ES2206770T3
ES2206770T3 ES98102962T ES98102962T ES2206770T3 ES 2206770 T3 ES2206770 T3 ES 2206770T3 ES 98102962 T ES98102962 T ES 98102962T ES 98102962 T ES98102962 T ES 98102962T ES 2206770 T3 ES2206770 T3 ES 2206770T3
Authority
ES
Spain
Prior art keywords
calcium silicate
vitamin
substance
particles according
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98102962T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Claude Tritsch
Johann Ulm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2206770T3 publication Critical patent/ES2206770T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
ES98102962T 1997-02-28 1998-02-20 Particulas secas fluidas. Expired - Lifetime ES2206770T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH48297 1997-02-28
CH48297 1997-02-28

Publications (1)

Publication Number Publication Date
ES2206770T3 true ES2206770T3 (es) 2004-05-16

Family

ID=4188018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98102962T Expired - Lifetime ES2206770T3 (es) 1997-02-28 1998-02-20 Particulas secas fluidas.

Country Status (15)

Country Link
US (1) US6030645A (enExample)
EP (1) EP0867177B1 (enExample)
JP (1) JP4494539B2 (enExample)
KR (1) KR19980071798A (enExample)
CN (1) CN1146405C (enExample)
AU (1) AU734530B2 (enExample)
BR (1) BR9800788A (enExample)
CA (1) CA2229351C (enExample)
DE (1) DE59809832D1 (enExample)
DK (1) DK0867177T3 (enExample)
ES (1) ES2206770T3 (enExample)
ID (1) ID19841A (enExample)
NO (1) NO320488B1 (enExample)
PH (1) PH11998000410B1 (enExample)
TW (1) TW505528B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6165518A (en) * 1996-04-11 2000-12-26 Loders Croklaan B.V. Free flowing fat compositions
JP4027535B2 (ja) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
AU4331199A (en) * 1998-06-08 1999-12-30 University Of Georgia Research Foundation, Inc., The Recovery of used frying oils
AR020343A1 (es) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion.
US6914073B2 (en) * 1999-03-18 2005-07-05 Bristol Myers Squibb Company Vitamin formulation for cardiovascular health
DE60007576D1 (de) * 1999-03-18 2004-02-12 Bristol Myers Squibb Co Vitamin Formulierung für kardiovaskuläre Gesundheit
US6444227B1 (en) 1999-08-05 2002-09-03 Roche Vitamins Inc. Process for preparing fat soluble beadlets
US7056531B1 (en) 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
AT414205B (de) * 2000-06-20 2006-10-15 Vis Vitalis Lizenz & Handels Verfahren zur herstellung von ungesättigtem fettsäure-trockenkonzentrat
JP2002037727A (ja) * 2000-07-26 2002-02-06 Eisai Co Ltd 脂溶性薬物を配合した速崩性固形製剤及びその製造方法
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
US7179488B2 (en) * 2001-11-29 2007-02-20 Bob Sherwood Process for co-spray drying liquid herbal extracts with dry silicified MCC
WO2003092406A1 (en) * 2002-05-02 2003-11-13 Volker Kuellmer Coated, agglomerated phytochemicals
GB0310673D0 (en) 2003-05-09 2003-06-11 Givaudan Sa Alginate matrix particles
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050196439A1 (en) * 2003-10-24 2005-09-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Process for co-spray drying agents with dry silicified MCC
US20050214367A1 (en) * 2004-03-22 2005-09-29 Volker Kuellmer Processes for making coated phytochemicals and tocopherols and products formed therefrom
ES2390274T3 (es) * 2005-06-04 2012-11-08 Cognis Ip Management Gmbh Microcápsulas
NZ572106A (en) * 2006-03-31 2010-12-24 Rubicon Res Private Ltd Directly compressible composite for orally disintegrating tablets
CN101448408B (zh) * 2006-05-19 2013-02-13 弗门尼舍有限公司 一步喷雾干燥法
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
LT2487163T (lt) 2007-02-23 2016-10-25 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
BRPI0911871A8 (pt) 2008-05-02 2018-03-06 Gilead Sciences Inc uso de partículas veículo sólidas para melhorar a processabilidade de um agente farmacêutico
GB201102557D0 (en) * 2011-02-14 2011-03-30 Univ Nottingham Oil bodies
JP5791304B2 (ja) * 2011-02-17 2015-10-07 アサヒフードアンドヘルスケア株式会社 ビタミンｃ類の反応抑制方法、及び、ビタミンｃ類を含む食品等製品
EA201991467A1 (ru) * 2016-12-15 2019-11-29 Состав смеси, содержащий силикат и микробные и/или растительные клетки и полиненасыщенную жирную кислоту, имеющую по меньшей мере 20 атомов углерода (lc-pufa)
WO2019068798A1 (en) * 2017-10-05 2019-04-11 Purac Biochem B.V. LACTATE POWDER AND PROCESS FOR THE PREPARATION THEREOF
CN109221869A (zh) * 2018-10-25 2019-01-18 广州市炜鑫生物科技有限公司 一种复合酵素纤维素固体饮料及其制备方法
CN110917071B (zh) * 2019-12-23 2022-11-08 万华化学集团股份有限公司 核壳结构柔珠、其制备方法及包括其的个人护理用品
CN117122069A (zh) * 2022-05-19 2023-11-28 仙乐健康科技股份有限公司 一种颗粒和包含所述颗粒的酸性食品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
US2858215A (en) * 1956-07-02 1958-10-28 Barnett Lab Inc Process of preparing vitamin oils in particle form
US3247064A (en) * 1962-03-30 1966-04-19 Shionogi & Co Multivitamin tablet stabilized with porous silica
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
US4603143A (en) * 1983-05-02 1986-07-29 Basf Corporation Free-flowing, high density, fat soluble vitamin powders with improved stability
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
US4780309A (en) * 1987-06-16 1988-10-25 Warner-Lambert Company Edible aerosol foam compositions and method of preparing same
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
US5837790A (en) * 1994-10-24 1998-11-17 Amcol International Corporation Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof

Also Published As

Publication number Publication date
DK0867177T3 (da) 2004-01-26
MX9801512A (enExample) 1999-04-01
PH11998000410B1 (enExample) 2002-07-05
JPH10245348A (ja) 1998-09-14
ID19841A (id) 1998-08-06
CN1194827A (zh) 1998-10-07
US6030645A (en) 2000-02-29
DE59809832D1 (de) 2003-11-13
KR19980071798A (ko) 1998-10-26
MX205481B (enExample) 2001-12-13
JP4494539B2 (ja) 2010-06-30
AU734530B2 (en) 2001-06-14
CA2229351A1 (en) 1998-08-28
AU5638498A (en) 1998-09-03
NO980840D0 (no) 1998-02-27
EP0867177A1 (de) 1998-09-30
NO980840L (no) 1998-08-31
CN1146405C (zh) 2004-04-21
NO320488B1 (no) 2005-12-12
BR9800788A (pt) 2000-04-04
CA2229351C (en) 2009-04-14
TW505528B (en) 2002-10-11
EP0867177B1 (de) 2003-10-08

Similar Documents

Publication Publication Date Title
ES2206770T3 (es) Particulas secas fluidas.
ES2647356T3 (es) Forma de dosificación robusta de disolución rápida
Yendluri et al. Application of halloysite clay nanotubes as a pharmaceutical excipient
US6491950B1 (en) Controlled release pharmaceutical composition
AU669952B2 (en) Taste-masking compositions of ranitidine
US4568547A (en) Solid pharmaceutical compositions comprising MSM and their production
JP4129995B2 (ja) 水性媒体に迅速に懸濁する医薬組成物
KR102308973B1 (ko) 개선된 피모벤단의 약제학적 조성물
SG184950A1 (en) Fexofenadine-based composition and preparation process therefor
NZ236834A (en) Oral medicaments comprising pimobendan in dry mixture with citric acid
JP2006503842A (ja) アスコルビン酸コリン製剤
JPH0129764B2 (enExample)
ES2232949T3 (es) Composiciones estabilizadas a base de tibolona.
AU2008215659A1 (en) Pharmaceutical composition comprising microparticle oily suspension
JP2006517929A (ja) 溶融アグロメレーションを用いてアグロメレートを製造する方法
US3458623A (en) Composition
MXPA98001512A (en) Dry particles of flux li
WO2003004008A2 (en) Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate
WO2016038623A2 (en) Taste masked stable pharmaceutical dosage form
JPH11506473A (ja) 湿式粒状化方法
JPWO1997033571A1 (ja) エカドトリルの速放微分散性製剤
HK1147055A (en) Rapidly dissolving robust dosage form
HK1137654B (en) Rapidly dissolving robust dosage form